BOUNDLESS BIO REPORTS FIRST QUARTER 2025 FINANCIAL RESULTS AND BUSINESS HIGHLIGHTS
BOUNDLESS BIO INC: $138 MILLION CASH POSITION PROVIDES OPERATING RUNWAY INTO 2027
Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.